The medtech giant was forced to shave $US100 million off its revenue forecasts for capitalising on a competitor’s recall, with the stock falling 5 per cent.
Brisbane Times – Business
Business
More in:Business
Business
Aurum strikes 23g/t gold at West African gold project
Aurum Resources has landed another set of encouraging high-grade gold intercepts up to 23g/t gold ...
Business
Gateway zeroes in on emerging large-scale WA gold system near Wiluna
Gateway Mining has uncovered an extensive gold system at its Yandal project in WA, with ...
Business
Macquarie cops $35m fine for misleading conduct on millions of short sales
Macquarie Group has agreed to the fine after reaching a settlement with the corporate watchdog ...